Danaher DHR
Danaher FY 2024: revenue $23.9B, flat; diluted EPS $5.29
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0000313616-25-000043
- Document
- 10-K
- Exhibit 4.12
- Warrants or notes
- Exhibit 10.4
- Material contract
- Exhibit 10.5
- Material contract
- Exhibit 10.6
- Material contract
- Exhibit 10.7
- Material contract
- Exhibit 10.8
- Material contract
- Exhibit 10.24
- Material contract
Key figures from this report
These are the numbers Danaher reported for the year ended Dec 31, 2024, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$23.9BFlat against $23.9B in FY 202310-K income statement, on EDGAR
- Net income$3.9B−18% from $4.8B in FY 202310-K income statement, on EDGAR
- Diluted EPS$5.29−17% from $6.38 in FY 202310-K income statement, on EDGAR
- Cash and cash equivalents$2.1B−65% from $5.9B in FY 202310-K balance sheet, on EDGAR
- Cash from operations$6.7B−7% from $7.2B in FY 202310-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3823 and related industry codes: the same peer list as the financial tables.
- Thermo Fisher Scientific TMO public float $154.0B, Jun 27, 2025
- KLA KLAC public float $159.3B, Dec 31, 2025
- Trane Technologies TT public float $97.2B, Jun 30, 2025
- Roper Technologies ROP public float $60.8B, Jun 30, 2025
- Ametek AME public float $41.8B, Jun 30, 2025